{
    "2019-02-01": [
        [
            {
                "time": "",
                "original_text": "医药和周期行业“超级明星股”剖析",
                "features": {
                    "keywords": [
                        "医药",
                        "周期行业",
                        "明星股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "周期行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "卸下千亿市值包袱 康美药业抢占3万亿中医药大健康市场",
                "features": {
                    "keywords": [
                        "康美药业",
                        "中医药",
                        "大健康",
                        "市值"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "大健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "OTC药企投资逻辑浮现 老字号看稀缺 儿药看低渗透率",
                "features": {
                    "keywords": [
                        "OTC药企",
                        "投资逻辑",
                        "老字号",
                        "稀缺",
                        "儿药",
                        "低渗透率"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "OTC药企"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "严监管“药妆”被打回原形？ 行业人士称擦边球仍可打 其他违规处罚",
                "features": {
                    "keywords": [
                        "严监管",
                        "药妆",
                        "违规处罚"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "化妆品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}